Total Payments
$8,777
2024 Payments
$2,677
Companies
37
Transactions
372
Medicare Patients
1,902
Medicare Billing
$348,409
Payment Breakdown by Category
Food & Beverage$7,814 (89.0%)
Education$588.14 (6.7%)
Consulting$375.00 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,814 | 354 | 89.0% |
| Education | $588.14 | 16 | 6.7% |
| Consulting Fee | $375.00 | 2 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $920.97 | 39 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $696.98 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $635.49 | 32 | $0 (2024) |
| Horizon Therapeutics plc | $625.37 | 29 | $0 (2023) |
| ANI Pharmaceuticals, Inc. | $568.35 | 18 | $0 (2024) |
| Travere Therapeutics, Inc. | $530.47 | 6 | $0 (2024) |
| Vifor Pharma, Inc. | $500.10 | 23 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $459.85 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $456.94 | 31 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $451.69 | 18 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,677 | 90 | Travere Therapeutics, Inc. ($530.47) |
| 2023 | $1,951 | 85 | ANI Pharmaceuticals, Inc. ($337.56) |
| 2022 | $1,697 | 72 | Horizon Therapeutics plc ($272.14) |
| 2021 | $939.28 | 52 | Horizon Therapeutics plc ($196.96) |
| 2020 | $537.53 | 25 | Otsuka America Pharmaceutical, Inc. ($132.86) |
| 2019 | $319.76 | 17 | Relypsa, Inc. ($97.86) |
| 2018 | $344.09 | 15 | Mallinckrodt LLC ($232.41) |
| 2017 | $310.94 | 16 | Mallinckrodt LLC ($179.44) |
All Payment Transactions
372 individual payment records from CMS Open Payments — Page 5 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $0.55 | General |
| Category: Cardio-renal | ||||||
| 10/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Cardio-renal | ||||||
| 10/10/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $20.64 | General |
| 10/10/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: NEPHROLOGY | ||||||
| 10/04/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardio-renal | ||||||
| 09/26/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 09/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: Cardio-renal | ||||||
| 09/25/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $16.07 | General |
| Category: NEPHROLOGY | ||||||
| 09/13/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: KRYSTEXXA | ||||||
| 09/06/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Inflammation | ||||||
| 09/06/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $20.71 | General |
| 09/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: Cardio-renal | ||||||
| 08/22/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Inflammation | ||||||
| 08/21/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 08/03/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $123.88 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 07/31/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 07/21/2023 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Hyperkalemia | ||||||
| 07/19/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 344 | 565 | $83,610 | $47,626 |
| 2022 | 9 | 444 | 706 | $109,370 | $62,295 |
| 2021 | 8 | 450 | 752 | $136,140 | $77,395 |
| 2020 | 13 | 664 | 4,937 | $430,078 | $161,093 |
Total Patients
1,902
Total Services
6,960
Medicare Billing
$348,409
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 72 | 199 | $27,860 | $18,163 | 65.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 147 | $23,520 | $11,579 | 49.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 52 | $9,100 | $5,090 | 55.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 77 | $6,930 | $4,692 | 67.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $7,800 | $4,479 | 57.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,000 | $1,954 | 48.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 40 | $4,400 | $1,669 | 37.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 103 | 269 | $37,660 | $21,592 | 57.3% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Facility | 2022 | 37 | 46 | $16,100 | $8,780 | 54.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 70 | 76 | $13,300 | $8,070 | 60.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 120 | $13,200 | $7,317 | 55.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 100 | $9,000 | $5,593 | 62.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $8,800 | $5,363 | 60.9% |
| 36907 | Balloon dilation of dialysis segment with review by radiologist | Facility | 2022 | 17 | 23 | $5,750 | $2,680 | 46.6% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Facility | 2022 | 11 | 12 | $3,000 | $1,604 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 16 | $2,560 | $1,296 | 50.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 98 | 290 | $40,600 | $23,626 | 58.2% |
| 36902 | Insertion of needle and/or catheter into dialysis circuit and balloon dilation of dialysis segment, with imaging including radiological supervision and interpretation | Facility | 2021 | 75 | 117 | $40,950 | $22,489 | 54.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 78 | 82 | $14,350 | $8,845 | 61.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 91 | 119 | $12,350 | $7,459 | 60.4% |
| 36907 | Balloon dilation of dialysis segment, accessed through the skin, with imaging including radiological supervision and interpretation | Facility | 2021 | 31 | 46 | $11,500 | $5,425 | 47.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $6,200 | $3,905 | 63.0% |
| 36901 | Insertion of needle and/or catheter into dialysis circuit, with imaging including radiological supervision and interpretation | Facility | 2021 | 22 | 26 | $6,500 | $3,310 | 50.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 41 | $3,690 | $2,336 | 63.3% |
| 36902 | Insertion of needle and/or catheter into dialysis circuit and balloon dilation of dialysis segment, with imaging including radiological supervision and interpretation | Office | 2020 | 44 | 48 | $148,272 | $45,531 | 30.7% |
About Dr. Edin Basic, D.O
Dr. Edin Basic, D.O is a Internal Medicine healthcare provider based in Clinton Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1124206685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edin Basic, D.O has received a total of $8,777 in payments from pharmaceutical and medical device companies, with $2,677 received in 2024. These payments were reported across 372 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,814).
As a Medicare-enrolled provider, Basic has provided services to 1,902 Medicare beneficiaries, totaling 6,960 services with total Medicare billing of $348,409. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Clinton Township, MI
- Active Since 02/07/2008
- Last Updated 02/07/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124206685
Products in Payments
- ACTHAR (Biological) $1,149
- KRYSTEXXA (Biological) $743.61
- Veltassa (Drug) $651.49
- PURIFIED CORTROPHIN GEL (Drug) $630.47
- TAVNEOS (Drug) $500.77
- JYNARQUE (Drug) $459.85
- Kerendia (Drug) $456.94
- FARXIGA (Drug) $426.33
- TARPEYO (Drug) $377.66
- JARDIANCE (Drug) $287.26
- LUPKYNIS (Drug) $279.09
- Parsabiv (Drug) $156.42
- LOKELMA (Drug) $147.76
- RAYALDEE (Drug) $142.37
- ULTOMIRIS (Biological) $113.56
- Velphoro (Drug) $104.96
- IBSRELA (Drug) $102.20
- Auryxia (Drug) $96.45
- INJECTAFER (Drug) $91.75
- Tavneos (Drug) $78.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clinton Township
Linda Lu Kosal, D.o, D.O
Internal Medicine — Payments: $8,569
Internal Medicine $8,569
Bryan Eastes, Md, MD
Internal Medicine — Payments: $7,031
Internal Medicine $7,031
Dr. Harjeet Jhajj, D.o, D.O
Internal Medicine — Payments: $4,551
Internal Medicine $4,551
Dr. Amy Calati, D.o, D.O
Internal Medicine — Payments: $3,876
Internal Medicine $3,876
Elmoataz Ibrahim, M.d, M.D
Internal Medicine — Payments: $3,429
Internal Medicine $3,429
Dr. James Clinton, D.o, D.O
Internal Medicine — Payments: $3,079
Internal Medicine $3,079